NDC 68703-035

BaniFlu

Gelsemium, Influenzinum, Nux Vom

BaniFlu is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Native Remedies, Llc. The primary component is Gelsemium Sempervirens Root; Influenza A Virus A/new Caledonia/20/99 (h1n1) Antigen (propiolactone Inactivated); Influenza A Virus A/panama/2007/99 (h3n2) Antigen (propiolactone Inactivated); Influenza B Virus B/hong Kong/330/2001 Antigen (propiolactone Inactivated); Strychnos Nux-vomica Seed.

Product ID68703-035_e54cf84c-cbe9-4b12-b584-2066829440b7
NDC68703-035
Product TypeHuman Otc Drug
Proprietary NameBaniFlu
Generic NameGelsemium, Influenzinum, Nux Vom
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2013-01-02
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameNative Remedies, LLC
Substance NameGELSEMIUM SEMPERVIRENS ROOT; INFLUENZA A VIRUS A/NEW CALEDONIA/20/99 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/PANAMA/2007/99 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/HONG KONG/330/2001 ANTIGEN (PROPIOLACTONE INACTIVATED); STRYCHNOS NUX-VOMICA SEED
Active Ingredient Strength30 [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 68703-035-80

180 TABLET in 1 BOTTLE, GLASS (68703-035-80)
Marketing Start Date2013-01-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68703-035-80 [68703003580]

BaniFlu TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2013-01-02
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
GELSEMIUM SEMPERVIRENS ROOT30 [hp_C]/1

OpenFDA Data

SPL SET ID:8c35f401-dce0-434f-a755-a5aedde16c76
Manufacturer
UNII
UPC Code
  • 0810845016254
  • NDC Crossover Matching brand name "BaniFlu" or generic name "Gelsemium, Influenzinum, Nux Vom"

    NDCBrand NameGeneric Name
    68647-120BaniFluInfluenzinum , Bacillinum , Gelsemium , Lactose
    68703-035BaniFluGelsemium, Influenzinum, Nux vom

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.